D. E. Shaw & Co »

Taysha Gene Therapies shares owned by D. E. Shaw & Co

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by D. E. Shaw & Co from 13F filings

Historical chart of D. E. Shaw & Co investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by D. E. Shaw & Co

Quarter filed Position value Share count Share price at filing
2025-09-30 $8.9M 2.7M 3.27
2025-06-30 $928k 402k 2.31
2022-09-30 $207k 107k 1.93
2022-06-30 $501k 135k 3.72
2022-03-31 $487k 75k 6.52
2021-06-30 $243k 11k 21.23

More positions owned by D. E. Shaw & Co

NVIDIA Corporation (NVDA)
Microsoft Corporation Put Option (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Palantir Technologies Cl A Call Option (PLTR)
Micron Technology Put Option (MU)
Tesla Motors (TSLA)
Broadcom Call Option (AVGO)
Meta Platforms Cl A Call Option (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Option (AAPL)
Netflix Put Option (NFLX)
Booking Holdings (BKNG)
Robinhood Mkts Com Cl A Put Option (HOOD)
Amazon (AMZN)
Western Digital Put Option (WDC)

View all positions for D. E. Shaw & Co

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies